17β-estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 274, Issue 3 43-3, 1998, Pages

  Binko, J ^a   Majewski, H ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Estrogen receptors; Vascular smooth muscle

Indexed keywords

ACETYLCHOLINE; ANTIESTROGEN; ARGININE; CITRULLINE; CYCLOHEXIMIDE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; ESTRADIOL; FULVESTRANT; N5 (1 IMINOETHYL)ORNITHINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; PROGESTERONE; PROTEIN SYNTHESIS INHIBITOR; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM INJURY; ENZYME INDUCTION; FEMALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

EID: 33750865905     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.274.3.h853     Document Type: Article

References (36)

1. Abraham, G. E., W. D. Odell, R. S. Swerdloff, and K. Hopper. Simultaneous radioimmunoassay of plasma FSH, GH, progesterone, 17-hydroxy-progesterone, and 17β-estradiol during the menstrual cycle. J. Clin. Endocrinol. Metab. 34: 312-316, 1972.
2. Bell, D. R., H. J. Rensberger, D. R. Koritnik, and A. Koshy. Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H377-H383, 1995.
3. Bredt, D. S., and S. H. Snyder. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87: 682-685, 1990.
4. Campisi, D., A. Bivona, S. Paterna, M. Valenza, and R. Albiero. Oestrogen binding sites in fresh human aortic tissue. Int. J. Tissue React. 9: 393-398, 1987.
5. Chartrain, N. A., D. A. Geller, P. P. Koty, N. F. Sitrin, A. K. Nussler, E. P. Hoffman, T. R. Billiar, N. I. Hutchinson, and J. S. Mudgett. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J. Biol. Chem. 269: 6765-6772, 1994.
6. Collins, P., J. Shay, C. Jiang, and J. Moss. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation 90: 1964-1968, 1994.
7. Dusting, G. J. Nitric oxide in cardiovascular disorders. J. Vasc. Res. 32: 143-161, 1995.
8. Ellerington, M. C., S. I. Whitcroft, and M. I. Whitehead. HRT: developments in therapy. Br. Med. Bull. 48: 401-425, 1992.
9. Fuller, P. J. The steroid receptor superfamily: mechanisms of diversity. FASEB J. 5: 3092-3099, 1991.
10. Geng, Y. J., M. Almqvist, and G. K. Hansson. cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells. Biochim. Biophys. Acta 1218: 421-424, 1994.
11. Gilligan, D. M., R. N. Badar, J. A. Panza, A. A. Quyyumi, and R. O. Cannon III. Acute vascular effects of estrogen in postmenopausal women. Circulation 90: 786-791, 1994.
12. Gisclard, V., V. M. Miller, and P. M. Vanhoutte. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J. Pharmacol. Exp. Ther. 244: 19-22, 1988.
13. Goetz, R. M., I. Morano, T. Calovini, R. Studer, and J. Holtz. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem. Biophys. Res. Commun. 205: 905-910, 1994.
14. Hannson, G. K., Y. J. Geng, J. Holm, P. Hardhammar, A. Wennmalm, and E. Jennische. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J. Exp. Med. 180: 733-738, 1994.
15. Huang, J., K. F. Roby, J. L. Pace, S. W. Russell, and J. S. Hunt. Cellular localization and hormonal regulation of inducible nitric oxide synthase in cycling mouse uterus. J. Leukoc. Biol. 57: 27-35, 1995.
16. Jiang, C., P. M. Sarrel, P. Collins, and P. A. Poole-Wilson. Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H271-H275, 1992.
17. Jiang, C., P. M. Sarrel, D. C. Lindsay, P. A. Poole-Wilson, and P. Collins. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br. J. Pharmacol. 104: 1033-1037, 1991.
18. Karas, R. H., B. L. Patterson, and M. E. Mendelson. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89: 1943-1950, 1994.
19. Katzenellenbogen, B. S. Estrogen receptors: bioactivities and interactions with cell signalling pathways. Biol. Reprod. 54: 287-293, 1996.
20. Killiam, A. P., C. R. Rosenfeld, F. C. Battaglia, E. L. Makowski, and G. Meschia. Effect of estrogens on the uterine blood flow of oophorectomized ewes. Am. J. Obstet. Gynecol. 115: 1045-1052, 1975.
21. Knowles, R. G., and S. Moncada. Nitric oxide synthase in mammals. Biochem. J. 298: 249-259, 1994.
22. McCall, T. B., M. Feelisch, R. M. Palmer, and S. Moncada. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br. J. Pharmacol. 102: 234-238, 1990
23. Miller, V. M., and P. M. Vanhoutte. 17β-Estradiol augments endothelium-dependent contractions to arachidonic acid in rabbit aorta. Am. J. Physiol. 258 (Regulatory Integrative Comp. Physiol. 27): R1502-R1507, 1990.
24. Miller, V. M., and P. M. Vanhoutte. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am. J. Physiol. 261 (Regulatory Integrative Comp. Physiol. 30): R1022-R1027, 1991.
25. Mügge, A., M. Riedel, M. Barton, M. Kuhn, and P. R. Lichtlen. Endothelium independent relaxation of human coronary arteries by 17β-oestradiol in vitro. Cardiovasc. Res. 27: 1939-1942, 1993.
26. Parratt, J. R., and L. Szekeres. Delayed protection of the heart against ischaemia. Trends Pharmacol. Sci. 16: 351-355, 1995.
27. Reis, S. E., S. T. Gloth, R. S. Blumenthal, J. R. Resar, H. A. Zacur, G. Gerstenblith, and J. A. Brinker. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 89: 52-60, 1994.
28. Resnik, R., G. W. Brink, and M. H. Plummer. The effects of progesterone on estrogen-induced uterine blood flow. Am. J. Obstet. Gynecol. 128: 251-254, 1977.
29. Rolland, R., R. M. Lequin, L. A. Schellekens, and F. H. De Jong. The role of prolactin in the restoration of ovarian function during the early postpartum period in the human female. Clin. Endocrinol. 4: 15-25, 1975.
30. Stampfer, M. J., G. A. Colditz, W. C. Willett, J. E. Manson, B. Rosner, F. E. Speizer, and C. H. Hennekens. Postmenopausal estrogen therapy and cardiovascular disease. N. Engl. J. Med. 325: 756-762, 1991.
31. Van Buren, G. A., D. S. Yang, and K. E. Clark. Estrogen-induced uterine vasodilation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am. J. Obstet. Gynecol. 16: 828-833, 1992.
32. Wakeling, A. E., M. Dukes, and J. Bowler. A potent specific pure antiestrogen with clinical potential. Cancer Res. 51: 3867-3873, 1991.
33. Weiner, C. P., I. Lizasoain, S. A. Baylis, R. G. Knowles, I. G. Charles, and S. Moncada. Induction of calcium dependent nitric oxide synthase by sex hormones. Proc. Natl. Acad. Sci. USA 91: 5212-5216, 1994.
34. Williams, J. K., M. R. Adams, and S. Klopfenstein. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81: 1680-1686, 1990.
35. Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 273: 199-208, 1995.
36. Xing, S., and S. Z. Cekan. Isotope effects of tritium in ligand-antibody binding. Int. J. Appl. Radiat. Isot. 34: 957-958, 1983.